Colitis ulcerosa: vizsgálatok itt: Argentína
9 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2. fázisCsak meghívásosLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Lujan de Cuyo, Rosario
- Életkor
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - 2. fázisTaking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Buenos Aires, Mendoza, Quilmes, Rosario, San Isidro, San Miguel de Tucumán
- Életkor
- 18 év to 80 év
- People
- 1431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Rosario
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Buenos Aires, Famailla, La Plata, Mendoza, Quilmes, Rosario, San Fernando
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - 1/2. fázisTaking peopleStudy of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Where
- Buenos Aires, Rosario, San Miguel de Tucumán
- Életkor
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06619990 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- La Plata, Lujan de Cuyo, Rosario, San Miguel de Tucumán
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Córdoba
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Rosario
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - No phaseTaking peopleArgentine Registry of Crohn's Disease and Ulcerative Colitis
- Where
- Córdoba
- People
- 4250
- Run by
- Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa
See details and how to joinNCT07155148